Document is current
Any future updates will be listed below
-
Authors
Wang, Baiyun https://orcid.org/0000-0003-2489-817X
Zheng, Ning https://orcid.org/0000-0002-1039-1581
-
Funding
Funding for this research was provided by:
Howard Hughes Medical Institute
Washington Research Foundation
U.S. Department of Health & Human Services | National Institutes of Health (R01 HD097408, R01 DA056370, R01HL112808, R01 HD097408, R01 DA056370, R01HL112808)
- License Information
-
More Information
Article History
Received: 15 February 2025
Accepted: 23 September 2025
First Online: 14 November 2025
Competing interests
: N.Z. is one of the scientific cofounders and a shareholder of SEED Therapeutics, and serves as a member of the scientific advisory boards of SyntheX, Molecular Glue Labs, Cold Start Therapeutics and Differentiated Therapeutics, with financial interests. B.W. declares no competing interests.
